Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A three-year-analysis of fixed drug eruptions in hospital settings in France.
Brahimi N, Routier E, Raison-Peyron N, Tronquoy AF, Pouget-Jasson C, Amarger S, Machet L, Amsler E, Claeys A, Sassolas B, Leroy D, Grange A, Dupuy A, Cordel N, Bonnetblanc JM, Milpied B, Doutre MS, Guinnepain MT, Barbaud A, Chosidow O, Roujeau JC, Lebrun-Vignes B, Descamps V. Brahimi N, et al. Among authors: sassolas b. Eur J Dermatol. 2010 Jul-Aug;20(4):461-4. doi: 10.1684/ejd.2010.0980. Epub 2010 May 27. Eur J Dermatol. 2010. PMID: 20507840
Drug-induced skin, nail and hair disorders.
Valeyrie-Allanore L, Sassolas B, Roujeau JC. Valeyrie-Allanore L, et al. Among authors: sassolas b. Drug Saf. 2007;30(11):1011-30. doi: 10.2165/00002018-200730110-00003. Drug Saf. 2007. PMID: 17973540 Review.
Severe cutaneous adverse reactions due to inappropriate medication use.
Chaby G, Valeyrie-Allanore L, Duong TA, Lebrun-Vignes B, Milpied B, Sassolas B, Tetart F, Wolkenstein P, Chosidow O, Fardet L. Chaby G, et al. Among authors: sassolas b. Br J Dermatol. 2018 Aug;179(2):329-336. doi: 10.1111/bjd.16365. Epub 2018 May 14. Br J Dermatol. 2018. PMID: 29352771
[Management of drug reaction with eosinophilia and systemic symptoms (DRESS)].
Descamps V, Ben Saïd B, Sassolas B, Truchetet F, Avenel-Audran M, Girardin P, Guinnepain MT, Mathelier-Fusade P, Assier H, Milpied B, Modiano P, Lebrun-Vignes B, Barbaud A; groupe Toxidermies de la Société française de dermatologie. Descamps V, et al. Among authors: sassolas b. Ann Dermatol Venereol. 2010 Nov;137(11):703-8. doi: 10.1016/j.annder.2010.04.024. Epub 2010 Aug 5. Ann Dermatol Venereol. 2010. PMID: 21074653 French.
Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients.
Chabbert C, Adamski H, Guillet G, Sassolas B, Misery L, Perrinaud A, Machet L, Quereux G, Esteve E, Solau-Gervais E, Saraux A, Polard E, Lesimple T, Le Gall F, Dreno B, Dupuy A. Chabbert C, et al. Among authors: sassolas b. J Eur Acad Dermatol Venereol. 2014 Nov;28(11):1540-4. doi: 10.1111/jdv.12347. Epub 2013 Dec 13. J Eur Acad Dermatol Venereol. 2014. PMID: 24329560
A randomized, investigator-masked, double-blind, placebo-controlled trial on thalidomide in severe cutaneous sarcoidosis.
Droitcourt C, Rybojad M, Porcher R, Juillard C, Cosnes A, Joly P, Lacour JP, D'Incan M, Dupin N, Sassolas B, Misery L, Chevrant-Breton J, Lebrun-Vignes B, Desseaux K, Valeyre D, Revuz J, Tazi A, Chosidow O, Dupuy A. Droitcourt C, et al. Among authors: sassolas b. Chest. 2014 Oct;146(4):1046-1054. doi: 10.1378/chest.14-0015. Chest. 2014. PMID: 24945194 Clinical Trial.
Risk factors for erysipelas of the leg (cellulitis): case-control study.
Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, Sassolas B, Guillaume JC, Grob JJ, Bastuji-Garin S. Dupuy A, et al. Among authors: sassolas b. BMJ. 1999 Jun 12;318(7198):1591-4. doi: 10.1136/bmj.318.7198.1591. BMJ. 1999. PMID: 10364117 Free PMC article.
[Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment].
Ingen-Housz-Oro S, Assier H, Gener G, Milpied B, Soria A, Bernier C, Descamps V, Tetart F, Staumont-Sallé D, Valeyrie-Allanore L, Valois A, Sassolas B, Bensaid B, Lebrun-Vignes B, Barbaud A; Groupe FISARD de la SFD. Ingen-Housz-Oro S, et al. Among authors: sassolas b. Ann Dermatol Venereol. 2019 Apr;146(4):313-318. doi: 10.1016/j.annder.2019.01.010. Epub 2019 Mar 21. Ann Dermatol Venereol. 2019. PMID: 30904277 French. No abstract available.
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P, Reguiai Z, Tancrède-Bohin E, Cordel N, Plantin P, Pauwels C, Vaillant L, Grange F, Richard-Lallemand MA, Sassolas B, Roujeau JC, Lok C, Picard-Dahan C, Chosidow O, Vitry F, Joly P. Bernard P, et al. Among authors: sassolas b. Arch Dermatol. 2009 May;145(5):537-42. doi: 10.1001/archdermatol.2009.53. Arch Dermatol. 2009. PMID: 19451497
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, Tancrede-Bohin E, Sassolas B, Lok C, Guillaume JC, Doutre MS, Richard MA, Caux F, Prost C, Plantin P, Chosidow O, Pauwels C, Maillard H, Saiag P, Descamps V, Chevrant-Breton J, Dereure O, Hellot MF, Esteve E, Bernard P. Joly P, et al. Among authors: sassolas b. J Invest Dermatol. 2009 Jul;129(7):1681-7. doi: 10.1038/jid.2008.412. Epub 2009 Jan 29. J Invest Dermatol. 2009. PMID: 19177141 Free article. Clinical Trial.
182 results